Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1Rahul Banerjee, Matthew C Cheung, Benjamin Derman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living GuidelineLisa K Hicks, Hans J Messersmith, Samer Al Hadidi, et al.
Blood|April 25, 2025
A phase 2 randomized study of modakafusp alfa as a single agent in patients with relapsed/refractory multiple myelomaSarah A Holstein, Shebli Atrash, Hira Mian, et al.
Blood Cancer Journal|April 2, 2025
Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group StudyCarlyn Rose Tan, Sireesha Asoori, Chiung-Yu Huang, et al.
Cancer|April 6, 2023
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myelomaNaresh Bumma, Binod Dhakal, Raphael Fraser, et al.
Blood Cancer Journal|April 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR studyDoris K Hansen, Danai Dima, Hira Mian, et al.
Bone Marrow Transplantation|October 5, 2021
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysisOren Pasvolsky, Moshe Yeshurun, Raphael Fraser, et al.
Transplantation and Cellular Therapy|June 16, 2026
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall SurvivalGurbakhash Kaur, Jennifer Logue, Ruta Brazauskas, et al.
Blood Advances|February 24, 2026
Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World AnalysisCarlyn Rose Tan, Saad Z Usmani, Andriy Derkach, et al.
Leukemia|January 27, 2025
International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myelomaLuciano J Costa, Rahul Banerjee, Hira Mian, et al.
Pageof 8